Developing capability using n w medicaid data FDA post-mrkt surv-access use during pregnancy
Ended Awarded Last action
- Contract number
- HHSF22301001T
- Awardee
-
Brigham & Womens Hospital Inc. UEI QN6MS4VN7BD1 Part of Partners Healthcare System Incorporated
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $2,963,836
Award facts
- Contract value 100% obligated
- $2,963,836.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Roxbury Crossing, 1400 Tremont St, Boston, MA 02120, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $2,963,836 |
About this award
The Department of Health and Human Services Food and Drug Administration awarded a $2,963,836.42 firm fixed price delivery order contract to Brigham & Women's Hospital Inc., a not-for-profit hospital and research institution in Boston, Massachusetts. The contract supports developing capability to use Medicaid data for FDA post-market drug safety surveillance during pregnancy. This contract is a task order under the FDA's Scientific Pharmacoepidemiologic Research Program, a larger indefinite delivery/indefinite quantity contract vehicle. No set-aside designation was indicated. Brigham & Women's Hospital has previously supported federal agencies including the Department of Veterans Affairs and Defense Health Agency through contracts and grants for research, data analytics, and IT services. The hospital's parent organization is Partners Healthcare System Incorporated, which has also participated as a subrecipient on various federal grants for COVID-19 response, cancer research, and community health programs.
Quick answers
Who was awarded contract HHSF22301001T?
HHSF22301001T was awarded to Brigham & Womens Hospital Inc. by Food and Drug Administration (Department of Health and Human Services) on September 20, 2017.
How much is contract HHSF22301001T worth?
The government has obligated $2,963,836 on HHSF22301001T.
Is contract HHSF22301001T an order under another contract?
Yes. HHSF22301001T is a delivery order under HHSF223201400043I, an indefinite delivery contract, on FDA Scientific Pharmacoepidemiologic Research Program.
Was contract HHSF22301001T competed?
The extent of competition for HHSF22301001T was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award